Clinical Trial Detail

NCT ID NCT04123470
Title A Phase I/II Trial Investigating LOAd703 in Combination With Atezolizumab in Malignant Melanoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Lokon Pharma AB
Indications

melanoma

Therapies

Atezolizumab + LOAd703

Age Groups: adult senior

No variant requirements are available.